Table 3. The association between metabolic syndrome severity and odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Occurrence in United States adults, the National Health and Nutrition Examination Survey (NHANES III) 1988–1994 (n = 10,605).

Metabolic Syndrome Severity	Unadjusted	Model 1	Model 2
	OR (95% CI)	OR (95% CI)	OR (95% CI)
Low	Reference	Reference	Reference
Moderate	1.69 (1.36 ⎯ 2.11)	1.80 (1.45 ⎯ 2.24)	1.26 (0.97 ⎯ 1.64)
High	3.67 (2.96 ⎯ 4.54)	3.99 (3.20 ⎯ 4.98)	2.27 (1.70 ⎯ 3.03)
Very High	6.08 (4.79 ⎯ 7.72)	6.60 (5.21 ⎯ 8.36)	3.12 (2.20 ⎯ 4.42)

Metabolic Syndrome Severity Group, the Metabolic Syndrome Z-score was transformed into four percentiles-based categories [low (0 – 50th), Moderate (>50th– 75th), High (>75th– 90th), and very-high (>90th)]

Model 1 = adjusted for age, sex, and race/ethnicity

Model 2 = Adjusted for age, sex, race/ethnicity, education level, access to health insurance, alcohol intake, smoking status, body mass index, abdominal obesity, physical activity, healthy eating index percentile, HOMA-IR, total cholesterol, and Aspartate Aminotransferase (AST)/alanine aminotransferase (ALT) Ratio

OR; odds ratio, CI; Confidence interval